heparin
one
main
pharmaceut
product
manufactur
raw
anim
materi
order
describ
viral
burden
associ
raw
materi
perform
highthroughput
sequenc
ht
mucu
sampl
destin
heparin
manufactur
collect
european
pig
identifi
circovirida
parvovirida
member
preval
contamin
virus
togeth
virus
picornavirida
astrovirida
reovirida
calicivirida
adenovirida
birnavirida
anellovirida
famili
put
new
viral
speci
also
identifi
load
sever
known
novel
small
nonenvelop
virus
particularli
difficult
inactiv
elimin
heparin
process
quantifi
qpcr
analysi
combin
ht
specif
qpcr
result
influenc
refin
valid
inactiv
procedur
well
aid
risk
analysi
viral
heparin
contamin
heparin
sodium
purifi
sodium
salt
heparin
high
molecular
weight
polysaccharid
deriv
porcin
intestin
mucosa
heparin
sodium
frequent
deriv
lowmolecularweight
heparin
lmwh
use
class
anticoagul
medic
porcin
heparin
prepar
either
porcin
intestin
mucosa
whole
minc
gut
one
pig
necessari
manufactur
three
dose
purifi
heparin
one
dose
lmwh
around
ton
heparin
manufactur
everi
year
worldwid
demand
heparin
sodium
lmwh
increas
last
year
current
million
pig
worldwid
use
manufactur
year
raw
materi
like
rich
enter
virus
gener
excret
high
titer
often
resist
mani
physic
chemic
treatment
therefor
recipi
human
patient
could
theoret
expos
porcin
virus
moreov
increas
knowledg
porcin
enter
virom
far
uncov
greater
viral
divers
previous
thought
heparin
manufactur
process
involv
numer
step
must
undergo
verif
efficaci
either
inactiv
remov
virus
accord
current
regul
help
build
contamin
risk
analys
establish
virus
monitor
investig
must
undertaken
determin
virus
like
contamin
raw
materi
respect
viral
load
highthroughput
sequenc
ht
techniqu
effici
detect
virus
present
biolog
fluid
review
ref
increasingli
use
medic
diagnosi
screen
biolog
materi
develop
pipelin
sampl
prepar
bioinformat
abl
identifi
known
well
new
virus
recent
demonstr
use
evalu
viral
burden
fetal
calf
serum
trypsin
use
cell
cultur
describ
analysi
virus
present
upstream
heparin
manufactur
process
show
divers
rang
known
unknown
virus
present
raw
materi
discuss
impact
result
establish
requir
futur
viral
valid
total
mucu
pool
sampl
collect
europ
reflect
divers
slaughterhous
util
singl
manufactur
sever
month
pool
repres
sever
hundr
pig
correspond
raw
materi
use
pure
heparin
sodium
manufactur
ml
mucu
sampl
mix
ml
nacetyl
cystein
merck
millipor
billerica
concentr
mgml
vortex
centrifug
min
rpm
c
supernat
filter
mm
filter
viru
particl
pool
independ
concentr
ultracentrifug
h
g
cushion
wv
sucros
pellet
resuspend
ml
water
treat
cocktail
nucleas
adapt
metagenom
studi
gut
content
digest
non
particleprotect
nucleic
acid
turbo
dnase
final
concentr
uml
ambion
rnase
final
concentr
mg
ml
fermenta
c
min
enzym
inactiv
final
concentr
mm
edta
heat
min
c
viru
particlesassoci
genom
contain
ml
mucu
pool
sampl
extract
cador
qiagen
pathogen
minikit
hilden
amplifi
bacteriophag
polymeras
base
multipl
displac
amplif
mda
assay
use
random
primer
techniqu
allow
dna
synthesi
dna
sampl
also
cdna
fragment
viral
genom
previous
collig
prior
polymerasemda
mix
ml
nucleic
acid
ml
primer
mm
ml
dntp
mm
incub
c
min
cool
ice
min
ml
enzym
mix
ad
enzym
mix
compos
ml
rt
buffer
ssiii
invitrogen
inc
saint
aubin
franc
ml
mm
mgcl
ml
dtt
ml
uml
rnaseout
invitrogen
inc
saint
aubin
franc
ml
superscript
iii
revers
transcriptas
invitrogen
inc
final
mix
incub
c
min
c
min
final
c
min
two
follow
step
ligat
mda
perform
quantitect
whole
transcriptom
kit
qiagen
accord
manufactur
instruct
ten
sampl
provid
concatem
high
molecular
weight
dna
concentr
close
mgml
pool
sequenc
sampl
extract
random
amplif
procedur
care
perform
prevent
crosscontamin
use
best
precautionari
pcr
standard
read
gener
illumina
sequenc
dnavis
goss
belgium
sequenc
depth
pairedend
read
nt
length
sequenc
trim
filter
accord
qualiti
score
sequenc
librari
prepar
may
introduc
residu
sampl
crosscontamin
porcin
genom
sequenc
subtract
sgsc
e
ncbi
project
wg
blastn
read
assembl
contig
use
clc
genom
assembl
workbench
cambridg
usa
contig
singleton
assign
given
taxonomi
use
blast
algorithm
criteria
taxonom
assign
describ
previous
sequenc
main
contig
avail
upon
request
quantit
pcr
use
quantifi
viru
load
known
candid
nonenvelop
virus
identifi
studi
sybr
green
qpcr
amplif
carri
reaction
volum
contain
ml
dna
master
mix
nm
forward
revers
primer
respect
tabl
lightcycl
sybr
green
master
roch
diagnost
meylan
franc
qpcr
analys
sampl
perform
duplic
conduct
indic
tabl
use
follow
primer
gener
primer
known
virus
porcin
bocaviru
specif
design
primer
base
major
contig
unknown
virus
calibr
curv
gener
use
purifi
amplicon
known
concentr
control
standard
studi
sponsor
involv
studi
design
data
collect
data
analysi
data
interpret
write
report
correspond
author
full
access
data
studi
final
respons
decis
submit
public
fig
depict
proport
read
correspond
sequenc
close
match
known
porcin
virus
vast
major
virus
found
nonenvelop
virus
except
read
relat
herpesvirida
famili
read
endogen
retrovirus
like
origin
contamin
porcin
dna
member
parvovirida
famili
repres
total
viral
read
within
group
member
bocaviru
genu
repres
parvovirida
read
follow
partetraviru
genu
member
shown
fig
member
circovirida
famili
repres
total
viral
read
mostli
compos
virus
remain
read
map
pocircolik
viru
data
shown
sequenc
nihcqv
viru
known
contamin
qiagen
extract
column
also
identifi
discard
frequent
read
picornavirida
virus
specif
newli
describ
genu
propos
pasiviru
account
read
data
shown
viral
famili
picobirnavirida
reovirida
mainli
rotaviru
c
adenovirida
mainli
pav
b
astrovirida
calicivirida
mainli
porcin
sapoviru
also
repres
much
lower
frequenc
put
new
viral
speci
also
identifi
address
studi
aim
focus
virus
could
challeng
remov
manufactur
process
belong
famili
known
either
physic
resist
small
size
tabl
detail
result
present
supplementari
tabl
identifi
potenti
novel
viral
speci
astrovirida
calicivirida
circovirida
parvovirida
reovirida
famili
frequent
read
correspond
member
parvovirida
famili
distantli
relat
around
amino
acid
ident
known
parvovirus
close
relat
eidolon
helvum
parvoviru
unclassifi
member
partetraviru
genu
found
frugivor
bat
africa
suggest
presenc
least
one
new
porcin
parvoviru
speci
tent
name
porcin
parvoviru
fig
show
cluster
eidolon
helvum
parvoviru
togeth
might
defin
new
genu
parvovirida
famili
also
identifi
new
virus
relat
circovirida
famili
distant
enter
virus
previous
describ
porcin
circoviruslik
pocircolik
well
columbid
duck
circovirus
data
shown
novel
astrovirus
rotavirus
also
identifi
addit
also
identifi
sequenc
map
viru
birnavirida
famili
similar
chicken
infecti
bursal
diseas
might
repres
first
report
incid
birnaviru
found
mammal
might
deriv
partial
digest
avian
food
assess
frequenc
load
nonenvelop
virus
correspond
highest
viral
read
count
test
ten
mucu
pool
use
qpcr
specif
target
relev
virus
porcin
bocaviru
parvovirida
famili
addit
estim
challeng
unknown
viru
might
bring
product
process
also
test
newli
discov
tabl
determin
batch
mucu
contain
high
load
nonenvelop
virus
highest
load
record
log
gcml
follow
parvovirida
member
log
gcml
averag
mucu
batch
contain
log
gcml
bocaviru
describ
viral
burden
pig
intestin
mucu
frequent
use
raw
anim
materi
manufactur
biolog
product
heparin
knowledg
first
broad
viral
analysi
materi
show
numer
viral
sequenc
present
raw
pig
intestin
mucu
expect
sampl
directli
deriv
gut
content
materi
util
highthroughput
sequenc
nucleasetr
pellet
result
ultracentrifug
like
sequenc
obtain
correspond
whole
viru
particl
even
total
exclud
nonencapsid
nucleic
acid
protect
within
aggreg
might
also
influenc
result
total
viral
content
domin
nonenvelop
virus
typic
enter
virus
identifi
member
circovirida
parvovirida
famili
major
mucuscontamin
virus
fecal
pig
virom
theori
similar
mucos
virom
examin
recent
via
ht
find
similar
relat
main
viru
famili
identifi
nevertheless
proport
viru
famili
gener
differ
could
perhap
due
variat
anim
studi
conduct
individu
pig
one
limit
number
herd
emphas
identifi
virus
porcin
pathogen
exampl
whilst
main
detect
speci
respons
postwean
multisystem
wast
syndrom
seem
nonpathogen
porcin
bocavirus
divers
yet
associ
diseas
interest
find
test
guidelin
viral
safeti
biolog
product
domin
search
porcin
pathogen
evid
due
bia
veterinari
virolog
domin
research
anim
diseas
inde
zoonot
virus
infect
human
either
weakli
pathogen
anim
reservoir
therefor
remain
cautiou
predict
impact
nonpathogen
anim
virus
human
health
moreov
mainli
detect
positivessrna
ssdna
virus
known
harbor
mark
capabl
adapt
new
host
follow
success
initi
cross
transmiss
event
hand
detect
virus
known
transmiss
human
influenza
hev
emcv
zoonot
statu
identifi
virus
rotaviru
noroviru
still
subject
fierc
debat
level
sensit
pipelin
close
pcr
known
virus
shown
previous
depth
sequenc
close
million
read
per
sampl
confirm
recent
higher
depth
sequenc
similar
use
studi
addit
allow
better
genom
coverag
seem
unlik
high
load
viru
abl
challeng
drastic
manufactur
process
heparin
could
escap
detect
pipelin
also
shown
detect
virus
distant
known
speci
paper
remain
inde
possibl
viru
far
alreadi
present
databas
might
escap
detect
number
ng
read
proport
rel
abund
viral
genom
differ
genom
type
singl
doubl
strand
dnarna
amplifi
differ
also
coverag
viral
genom
gener
uniform
current
imposs
estim
viru
load
ng
result
due
studi
object
result
viral
divers
decid
focu
quantit
analysi
subset
virus
may
especi
resili
remov
inactiv
manufactur
process
ie
circovirida
parvovirida
resist
physic
chemic
inactiv
addit
smallest
vertebr
virus
nm
nm
respect
thu
difficult
clear
nanofiltr
among
parvovirida
chose
two
speci
porcin
bocaviru
repres
parvovirida
read
new
viru
model
unknown
virus
would
detect
use
current
pcr
method
circovirus
two
parvovirus
present
batch
detect
batch
viral
load
high
remark
similar
batch
probabl
consequ
frequent
shed
larg
size
test
pool
sever
hundr
pig
probabl
averag
viral
load
ten
mucu
batch
contain
log
gcml
sever
nonenvelop
small
dna
virus
repres
sever
challeng
downstream
purif
process
anim
sourc
worldwid
heparin
purif
includ
anim
north
america
china
consequ
mucu
sampl
collect
european
herd
result
may
repres
mucu
sourc
nevertheless
like
certain
resid
virus
repres
viral
profil
characterist
anim
speci
analysi
take
account
geograph
sourc
variat
complic
multipl
pig
strain
neither
examin
impact
enter
viral
diseas
could
viral
excret
coronavirus
porcin
epidem
diarrhea
viru
pedv
transmiss
gastroenter
viru
tgev
rotavirus
prva
major
porcin
virus
caus
enter
diseas
even
reovirida
member
includ
rotavirus
poorli
repres
viral
count
coronavirus
identifi
inclus
herd
acut
viral
diarrhea
would
like
modifi
mucos
viral
composit
result
help
defin
guidelin
appropri
valid
procedur
inactiv
pertin
resist
virus
like
parvovirus
circovirus
two
main
adventiti
virus
reveal
valid
inactiv
process
porcin
parvoviru
ppv
parvovirida
member
would
repres
relev
refer
viru
use
circoviru
would
also
aid
valid
challeng
nanofiltr
step
choic
envelop
virus
classic
use
valid
manufactur
process
appear
lower
interest
compar
risk
raw
materi
contamin
assess
evalu
probabl
surviv
virus
final
product
would
necessit
subtract
reduct
factor
valid
step
process
load
virus
upstream
process
outlin
scope
paper
would
necessit
know
viral
titer
mucu
studi
also
amount
mucu
use
manufactur
dose
valid
reduct
factor
manufactur
process
current
mucu
sampl
undergo
viral
test
prior
process
case
assay
would
uninform
mucu
sampl
contain
virus
moreov
neither
bionor
molecular
assay
avail
sever
viru
type
heparin
safeti
thu
reli
effici
inactiv
andor
remov
capabl
process
use
combin
ng
analysi
quantit
pcr
techniqu
feasibl
character
viral
burden
raw
materi
result
indepth
data
viral
speci
load
would
guid
select
virus
use
valid
inactiv
process
could
also
use
build
risk
analys
need
releas
biolog
product
market
evolutionari
histori
infer
use
maximum
likelihood
method
base
jtt
matrixbas
model
tree
highest
log
likelihood
shown
initi
tree
heurist
search
obtain
automat
appli
neighborjoin
bionj
algorithm
matrix
pairwis
distanc
estim
use
jtt
model
select
topolog
superior
log
likelihood
valu
tree
drawn
scale
branch
length
measur
number
substitut
per
site
analysi
involv
partial
amino
acid
sequenc
put
protein
posit
contain
gap
miss
data
elimin
total
posit
final
dataset
evolutionari
analys
conduct
tree
label
accord
propos
new
genu
name
within
parvovirida
famili
